Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT1 | P17948 | 2/20 | 0.50 |
| ▸ | FLT4 | P35916 | 2/20 | 0.50 |
| ▸ | KDR | P35968 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 4/20 | 0.46 |
| ▸ | MAOA | P21397 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29526339 | 1.00 | FLT1 (0.50) | FLT1FLT4KDRMAOBMAOA | |
| SCHEMBL20981631 | 0.86 | FLT1 (0.46) | FLT1FLT4KDRMAOBMAOA | |
| SCHEMBL6626508 | 0.85 | HSD17B1 (0.44) | FLT1FLT4KDRMAOBMAOA | |
| SCHEMBL3121226 | 0.83 | F2R (0.48) | MAOBMAOASMN1; SMN2TSHRCASP1 | |
| SCHEMBL29494150 | 0.83 | F2R (0.48) | MAOBMAOASMN1; SMN2TSHRCASP1 | |
| SCHEMBL11810626 | 0.81 | SMN1; SMN2 (0.52) | FLT1FLT4KDRSMN1; SMN2TSHR | |
| SCHEMBL1164132 | 0.81 | FLT1 (0.51) | FLT1FLT4KDRMAOBSMN1; SMN2 | |
| SCHEMBL395189 | 0.81 | SMN1; SMN2 (0.63) | FLT1FLT4KDRSMN1; SMN2TSHR | |
| SCHEMBL15756559 | 0.81 | MAOA (0.48) | MAOBMAOAALDH1A1KMT2AMAPK1 | |
| SCHEMBL20117002 | 0.80 | ALDH1A1 (0.50) | MAOBMAOASMN1; SMN2TSHRCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113880786-A | Synthesis method and antioxidant application of camphene aldehyde thiazole hydrazone derivative | 江西农业大学 | 2022-01-04 | — | — | CN | claimed |
| US-12509474-B2 | Inhibitors of complement factors and uses thereof | ANNEXON, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250282748-A1 | SUBSTITUTED OXOPYRIDINE DERIVATIVES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2025-09-11 | — | — | US | disclosed |
| US-12404274-B2 | Macrocycles as factor xia inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-09-02 | — | — | US | disclosed |
| CN-118638059-A | Polymorphic form of FXIa inhibitor compound, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-115515938-B | Salts of FXIa inhibitor compounds, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-05-10 | — | — | CN | disclosed |
| US-20240109920-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON, INC. | 2024-04-04 | — | — | US | disclosed |
| CN-114685458-B | Organic compound and application thereof | 广州华睿光电材料有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-117586179-A | GPR183 antagonist and synthetic method and application thereof | 中国人民解放军海军特色医学中心 | 2024-02-23 | — | — | CN | disclosed |
| US-20240043422-A1 | METHODS FOR TREATING CANCER AND NON-NEOPLASTIC CONDITIONS | PTC THERAPEUTICS, INC. (US) | 2024-02-08 | — | — | US | disclosed |
| US-4259235-A | REDUCTION OF PLANT GROWTH HEIGHT | BASF AKTIENGESELLSCHAFT (DE) | 1981-03-31 | — | — | US | disclosed |
| US-4257941-A | PLANT GROWTH REGULATORS, HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1981-03-24 | — | — | US | disclosed |
| US-4251542-A | Imino compounds | CIBA-GEIGY CORPORATION (US) | 1981-02-17 | — | — | US | disclosed |
| US-4209447-A | FUNGICIDES, BACTERICIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1980-06-24 | — | — | US | disclosed |
| US-4189434-A | PLANT GROWTH REGULATORS | BASF AKTIENGESELLSCHAFT (DE) | 1980-02-19 | — | — | US | disclosed |
| EP-0001271-A1 | Heterocyclic norbornane derivatives, plant-growth regulating compositions containing these compounds and process for the preparation of these compositions | BASF Aktiengesellschaft (DE) | 1979-04-04 | — | — | EP | disclosed |
| US-4139540-A | FUNGICIDE, BACTERICIDE INTERMEDIATE | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-02-13 | — | — | US | disclosed |
| US-4130652-A | 2-(Iminoethylidene)-pyrrolidines and tautomeric 2-(aminoethenyl)-1-pyrrolines | CIBA-GEIGY CORPORATION (US) | 1978-12-19 | — | — | US | disclosed |
| US-4044131-A | B-ADRENERGIC BLOCKERS, FUNGICIDES, 4-ALKYL OR ALKYNYL, 6-ARYLOXYMETHYL | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-08-23 | — | — | US | disclosed |
| US-3936470-A | FUNGICIDES, BACTERICIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109920-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | CFB, CFH, C9 | FLT1 3910/4885FLT4 4082/4885KDR 3397/4885 |
| US-12404274-B2 | Macrocycles as factor xia inhibitors | TFPI, TFPI2, F11 | FLT1 147/4885FLT4 310/4885KDR 603/4885 |
| US-20240043422-A1 | METHODS FOR TREATING CANCER AND NON-NEOPLASTIC CONDITIONS | HDGF, POLRMT, VEGFA | FLT1 21/4885FLT4 17/4885KDR 23/4885 |
| US-12509474-B2 | Inhibitors of complement factors and uses thereof | SSB, UACA, CFH | FLT1 3949/4885FLT4 4363/4885KDR 2637/4885 |
| US-20250282748-A1 | SUBSTITUTED OXOPYRIDINE DERIVATIVES | OGFOD1, VASP, PNPO | FLT1 103/4885FLT4 104/4885KDR 79/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.